Trexquant Investment’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-19,548	Closed	-$73K	–	1845
2022 Q2	$73K	Sell	19,548 -51,935	-73%	-$194K	﹤0.01%	1450
2022 Q1	$466K	Buy	71,483 +41,852	+141%	+$273K	0.02%	797
2021 Q4	$345K	Buy	+29,631	New	+$345K	0.02%	845